z-logo
Premium
[Gly 14 ]‐Humanin improved the learning and memory impairment induced by scopolamine in vivo
Author(s) -
Mamiya Takayoshi,
Ukai Makoto
Publication year - 2001
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0704429
Subject(s) - memory impairment , cholinergic , in vivo , neuroscience , presenilin , spontaneous alternation , alzheimer's disease , psychology , pharmacology , endocrinology , biology , disease , medicine , hippocampus , cognition , genetics
Humanin is a very recently discovered 24 amino acid linear polypeptide, which protects against cell death induced by either familial Alzheimer's disease mutant of amyloid precursor protein, presenilin‐1 or presenilin‐2 in vitro . However, it has remained uncertain whether humanin is a useful drug for the animal model of learning and memory deficit. In this study, we evaluated the effects of [Gly 14 ]‐humanin, a more potent humanin analogue, on the scopolamine HBr (1 mg kg −1 s.c.)‐induced impairment of spontaneous alternation behaviour in the Y‐maze, an index of short‐term memory in mice. [Gly 14 ]‐Humanin (1000 pmol 5 μl −1 i.c.v.) reversed the impairment without affecting the number of arm entries. These results suggest that (I) [Gly 14 ]‐humanin is a beneficial drug for the impairment of learning and memory and (II) it modulates the learning and memory function mediated via cholinergic systems in mice. British Journal of Pharmacology (2001) 134 , 1597–1599; doi: 10.1038/sj.bjp.0704429

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom